| Literature DB >> 34068027 |
Claudine Fournier1, Patrice Nordmann2,3,4, Olivier Pittet5, Laurent Poirel2,3.
Abstract
Background. The aim of the present study was to prospectively evaluate the prevalence of intestinal carriage of colistin-resistant and extended-spectrum β-lactamase (ESBL)-producing Enterobacterales among pigs from a Swiss farm attending an animal health and antibiotic stewardship program and to determine the associated mechanisms of resistance. Materials/Methods. Eighty-one fecal samples were recovered and screened for either β-lactam-resistant, colistin-resistant, or aminoglycoside-resistant Enterobacterales, using respective screening media. All recovered isolates were tested for antimicrobial susceptibility and their clonal relationship (PFGE and MLST). Plasmid typing was performed by plasmid-based replicon typing (PBRT). Resistance genes were searched by PCR and sequencing. Results. A total of 38 ESBL-producing Escherichia coli and a single ESBL-producing Enterobacter cloacae were recovered from 81 pigs, corresponding to a prevalence of 50%, no other β-lactamase producer being identified. Among the 38 ESBL-producing E. coli, all belonged to sequence type (ST) ST10, except two ST34 and ST744 isolates. Among the ST10-blaCTX-M-1 isolates, three subclones (n = 22, n = 13, and n = 1, respectively) were identified according to the PFGE analysis. The most commonly identified IncI1 plasmid harboring the blaCTX-M-1 gene was 143 kb in size and coharbored other resistance genes. Only three colistin-resistant Enterobacterales isolates were recovered, namely two Klebsiella pneumoniae isolates and a single E. cloacae isolate. Screening for the plasmid-borne mcr-1 to mcr-9 genes in these three isolates gave negative results. The two K. pneumoniae isolates were clonally related, belonged to ST76, and harbored a truncated mgrB chromosomal gene being the source of colistin resistance. Conclusion. A high prevalence of fecal carriage of ESBL-producing E. coli was found, being mainly caused by the spread of a clonal lineage within the farm. By contrast, a low prevalence of colistin-resistant Enterobacterales was found.Entities:
Keywords: ESBL; colistin; mobilized colistin resistance; pigs
Year: 2021 PMID: 34068027 PMCID: PMC8152456 DOI: 10.3390/antibiotics10050574
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Rate and features of resistance isolates distribution in pig stables.
| Stable Number | Number of Pigs | Number of Resistant Isolates | Type of Livestock | Weight of Piglets | Clones Present | Rate of Pigs Carrying Resistant Strains | Resistant Determinant | Co-Resistance Phenotype |
|---|---|---|---|---|---|---|---|---|
| 1 | 8 | 7 | Fattening | 40 to 42 kg | A ( | 87.50% |
| SUL, TET a ( |
| None ( | ||||||||
| C ( |
| NAL, CIP, TET, SUL, CHL, FLO ( | ||||||
| 2 | 8 | 5 | Fattening | 40 to 42 kg | A ( | 62.50% |
| SUL ( |
| 3 | 6 | 2 | Fattening | 102 kg | A ( | 33.30% |
| SUL ( |
| B1 ( |
| SUL ( | ||||||
| 4 | 10 | 4 | Weaning | 18 to 20 kg | A ( | 40% |
| SUL ( |
| 5 | 10 | 8 | Weaning | 18 to 20 kg | A ( | 60% |
| SUL ( |
| B1 ( |
| SUL, TET ( | ||||||
| E ( |
| TET ( | ||||||
|
| SUL, TET ( | |||||||
| SUL ( | ||||||||
| 6 | 20 | 4 | Weaning | 9 to 10 kg | A ( | 20% |
| SUL ( |
| ND d | None ( | |||||||
| None ( | ||||||||
| 7 | 10 | 8 | Reproduction | - | B1 ( |
| SUL, TET ( | |
| D ( |
| GMI, KMN, TMN, SUL, TET ( | ||||||
| 8 | 3 | 2 | Sow b with 3 piglets | B1 ( | 66% |
| SUL, TET ( | |
| 9 | 3 | 2 | Sow c with 3 piglets | B2 ( | 33% |
| KMN, SUL, SXT, TET ( | |
| B1 ( | 33% |
| SUL, TET ( | |||||
| 10 | 3 | 1 | Sow d with 3 piglets | A ( | 33% |
| SUL ( |
a Antibiotic abbreviations: CHL—chloramphenicol; CIP—ciprofloxacin; FLO—florfenicol, SUL—sulfonamide; SXT—trimethoprime-sulfamethoxazol; GMI—gentamicin; KMN—kanamycin; NAL—nalidixic acid; TMN—tobramycin; TET—tetracycline. b Sow treated with 3 doses of Betamox (amoxicillin, 15 mg/kg, iv). c Sow treated with 2 doses of Borgal (sulfadoxin-trimethoprim 24%, 8–12 mL, iv) and Rifen (cetoprofen 10%, 3 mL/100 kg, iv). d Resistance to colistin, mechanism not determined. ND: not determined.
Phenotype and genetic features associated with the ESBL-positive isolates.
| Number of Isolates | Species | Phylogenic Group | ST | Pulsotype | Resistance Determinants | Incompatibility Group of the Plasmid Carrying | Coresistance on the Plasmid Carrying |
|---|---|---|---|---|---|---|---|
| 22 |
| A | ST10 | A |
| Inc I1 | TET, SUL a |
| 12 |
| A | ST10 | B1 b |
| Inc I1 | TET, SUL |
| 1 |
| A | ST10 | B2 b |
| IncI1 | GMI, KMN, TMN, SUL, TET |
| 1 |
| A | ST744 | C |
| Inc I1 | TET, SUL |
| 1 |
| A | ST34 | D |
| Inc I1 | TET, SUL |
| 1 |
| A | ST10 | E |
| Inc I1 | TET, SUL |
| 1 |
| ND |
| Inc I1 | TET, SUL |
a Antibiotic abbreviations: SUL—sulfonamides; TET—tetracycline; GMI—gentamicin; KMN—kanamycin; TMN—tobramycin; ND: not determined. b The pulsotype B was divided in B1 and B2 sub-pulsotypes according to co-resistance.
Figure 1Pulsed-field gel electrophoresis of CTX-M-1-positive E. coli isolates corresponding to pulsotypes A, B, C, D, and E.